サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1538524

全エクソームシーケンス市場レポート：2030年までの動向、予測、競合分析

Whole Exome Sequencing Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

全エクソームシーケンス市場レポート：2030年までの動向、予測、競合分析
出版日: 2024年07月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

全エクソームシーケンスの動向と予測

世界の全エクソームシーケンス市場は、2024年から2030年までのCAGRが14.6%で、2030年までに推定37億米ドルに達すると予測されます。この市場の主な促進要因は、科学技術におけるこのシーケンスの応用の拡大、ゲノムおよび次世代シーケンス技術の継続的な開拓、個別化医療に対する需要の高まりです。世界の全エクソームシーケンス市場の将来は、臨床診断、創薬・薬剤開発、個別化医療市場における機会によって有望視されています。

セグメント別全エクソームシーケンス

この調査には、世界の全エクソームシーケンスの製品別、技術別、用途別、最終用途別、地域別の予測が含まれています。

全エクソームシーケンス市場の洞察

Lucintel社は、消耗品が予測期間中に最も高い成長を遂げると予測しています。

この市場において、創薬および市場開拓は予測期間中最大のセグメントであり続けるでしょう。

北米は予測期間中最大の地域であり続けるでしょう。

よくある質問

Q1.市場規模は：

A1.世界の全エクソームシーケンス市場は、2030年までに推定37億米ドルに達すると予想されています。

Q2.市場の成長予測は：

A2.世界の全エクソームシーケンス市場は、2024年から2030年にかけてCAGR 14.6%で成長する見込みです。

Q3.市場の成長に影響を与える主な促進要因は：

A3.この市場の主な促進要因は、科学技術におけるこのシーケンスの応用の拡大、ゲノムおよび次世代シーケンシング技術の継続的開拓、個別化医療に対する需要の高まりです。

Q4.市場の主要セグメントは：

A4.全エクソームシーケンス市場の将来性は、臨床診断、創薬・薬剤開発、個別化医療市場における機会により有望視されています。

Q5.市場の主要企業は：

A5.主要な全エクソームシーケンス企業は以下の通りです：

  • Thermo Fisher Scientific
  • Illumina
  • Agilent Technologies
  • BGI
  • PacBio
  • Oxford Nanopore Technologies
  • Azenta
  • CD Genomics
  • Novogene
  • Eurofins Genomics

Q6.今後、最大となる市場セグメントは：

A6.Lucintelは、消耗品が予測期間で最も高い成長を遂げると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は：

A7.北米は予測期間中最大の地域であり続けます。

Q8.レポートのカスタマイズは可能か：

A8.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の全エクソームシーケンス市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の全エクソームシーケンス市場の動向（2018～2023年）と予測（2024～2030年）
  • 製品別世界全エクソームシーケンス市場
    • 装置
    • 消耗品
    • サービス
  • 技術別世界全エクソームシーケンス市場
    • 合成によるシーケンシング
    • ION半導体シーケンシング
    • その他
  • 用途別世界全エクソームシーケンス市場
    • 臨床診断
    • 医薬品の発見と開発
    • 個別化医療
    • その他
  • 最終用途別世界全エクソームシーケンス市場
    • 学術研究機関
    • 病院・クリニック
    • 製薬・バイオテクノロジー企業
    • その他

第4章 2018年から2030年までの地域別市場動向と予測分析

  • 地域別世界全エクソームシーケンス市場
  • 北米の全エクソームシーケンス市場
  • 欧州の全エクソームシーケンス市場
  • アジア太平洋の全エクソームシーケンス市場
  • その他地域全エクソームシーケンス市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 業務統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 製品別世界全エクソームシーケンス市場の成長機会
    • 技術別世界全エクソームシーケンス市場の成長機会
    • 用途別の世界全エクソームシーケンス市場の成長機会
    • 最終用途別世界全エクソームシーケンス市場の成長機会
    • 地域別の世界全エクソームシーケンス市場の成長機会
  • 世界の全エクソームシーケンス市場の新たな動向
  • 戦略分析
    • 新製品開発
    • 世界の全エクソームシーケンス市場の能力拡大
    • 世界の全エクソームシーケンス市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 主要企業の企業プロファイル

  • Thermo Fisher Scientific
  • Illumina
  • Agilent Technologies
  • BGI
  • PacBio
  • Oxford Nanopore Technologies
  • Azenta
  • CD Genomics
  • Novogene
  • Eurofins Genomics
目次

Whole Exome Sequencing Trends and Forecast

The future of the global whole exome sequencing market looks promising with opportunities in the clinical diagnostic, drug discovery & development, and personalized medicine markets. The global whole exome sequencing market is expected to reach an estimated $3.7 billion by 2030 with a CAGR of 14.6% from 2024 to 2030. The major drivers for this market are growing application of this sequencing in science and technology, ongoing development in genomics and next-generation sequencing technologies, and rising demand for personalized medicine.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Whole Exome Sequencing by Segment

The study includes a forecast for the global whole exome sequencing by product, technology, application, end use, and region.

Whole Exome Sequencing Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Consumables
  • Services

Whole Exome Sequencing Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Sequencing by Synthesis
  • ION Semiconductor Sequencing
  • Others

Whole Exome Sequencing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Clinical Diagnostics
  • Drug Discovery & Development
  • Personalized Medicines
  • Others

Whole Exome Sequencing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Academic & Research Institutes
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Others

Whole Exome Sequencing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Whole Exome Sequencing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies whole exome sequencing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the whole exome sequencing companies profiled in this report include-

  • Thermo Fisher Scientific
  • Illumina
  • Agilent Technologies
  • BGI
  • PacBio
  • Oxford Nanopore Technologies
  • Azenta
  • CD Genomics
  • Novogene
  • Eurofins Genomics

Whole Exome Sequencing Market Insights

Lucintel forecasts that consumable is expected to witness the highest growth over the forecast period.

Within this market, drug discovery & development will remain the largest segment over the forecast period.

North America will remain the largest region over the forecast period.

Features of the Global Whole Exome Sequencing Market

Market Size Estimates: Whole exome sequencing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Whole exome sequencing market size by various segments, such as by product, technology, application, end use, and region in terms of value ($B).

Regional Analysis: Whole exome sequencing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, technologies, applications, end uses, and regions for the whole exome sequencing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the whole exome sequencing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the whole exome sequencing market size?

Answer: The global whole exome sequencing market is expected to reach an estimated $3.7 billion by 2030.

Q2. What is the growth forecast for whole exome sequencing market?

Answer: The global whole exome sequencing market is expected to grow with a CAGR of 14.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the whole exome sequencing market?

Answer: The major drivers for this market are growing application of this sequencing in science and technology, ongoing development in genomics and next-generation sequencing technologies, and rising demand for personalized medicine.

Q4. What are the major segments for whole exome sequencing market?

Answer: The future of the whole exome sequencing market looks promising with opportunities in the clinical diagnostic, drug discovery & development, and personalized medicine markets.

Q5. Who are the key whole exome sequencing market companies?

Answer: Some of the key whole exome sequencing companies are as follows:

  • Thermo Fisher Scientific
  • Illumina
  • Agilent Technologies
  • BGI
  • PacBio
  • Oxford Nanopore Technologies
  • Azenta
  • CD Genomics
  • Novogene
  • Eurofins Genomics

Q6. Which whole exome sequencing market segment will be the largest in future?

Answer: Lucintel forecasts that consumable is expected to witness the highest growth over the forecast period.

Q7. In whole exome sequencing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the whole exome sequencing market by product (instruments, consumables, and services), technology (sequencing by synthesis, ion semiconductor sequencing, and others), application (clinical diagnostics, drug discovery & development, personalized medicines, and others), end use (academic & research institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Whole Exome Sequencing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Whole Exome Sequencing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Whole Exome Sequencing Market by Product
    • 3.3.1: Instruments
    • 3.3.2: Consumables
    • 3.3.3: Services
  • 3.4: Global Whole Exome Sequencing Market by Technology
    • 3.4.1: Sequencing by Synthesis
    • 3.4.2: ION Semiconductor Sequencing
    • 3.4.3: Others
  • 3.5: Global Whole Exome Sequencing Market by Application
    • 3.5.1: Clinical Diagnostics
    • 3.5.2: Drug Discovery & Development
    • 3.5.3: Personalized Medicines
    • 3.5.4: Others
  • 3.6: Global Whole Exome Sequencing Market by End Use
    • 3.6.1: Academic & Research Institutes
    • 3.6.2: Hospitals & Clinics
    • 3.6.3: Pharmaceutical & Biotechnology Companies
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Whole Exome Sequencing Market by Region
  • 4.2: North American Whole Exome Sequencing Market
    • 4.2.1: North American Whole Exome Sequencing Market by Product: Instruments, Consumables, and Services
    • 4.2.2: North American Whole Exome Sequencing Market by Application: Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, and Others
  • 4.3: European Whole Exome Sequencing Market
    • 4.3.1: European Whole Exome Sequencing Market by Product: Instruments, Consumables, and Services
    • 4.3.2: European Whole Exome Sequencing Market by Application: Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, and Others
  • 4.4: APAC Whole Exome Sequencing Market
    • 4.4.1: APAC Whole Exome Sequencing Market by Product: Instruments, Consumables, and Services
    • 4.4.2: APAC Whole Exome Sequencing Market by Application: Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, and Others
  • 4.5: ROW Whole Exome Sequencing Market
    • 4.5.1: ROW Whole Exome Sequencing Market by Product: Instruments, Consumables, and Services
    • 4.5.2: ROW Whole Exome Sequencing Market by Application: Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Whole Exome Sequencing Market by Product
    • 6.1.2: Growth Opportunities for the Global Whole Exome Sequencing Market by Technology
    • 6.1.3: Growth Opportunities for the Global Whole Exome Sequencing Market by Application
    • 6.1.4: Growth Opportunities for the Global Whole Exome Sequencing Market by End Use
    • 6.1.5: Growth Opportunities for the Global Whole Exome Sequencing Market by Region
  • 6.2: Emerging Trends in the Global Whole Exome Sequencing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Whole Exome Sequencing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Whole Exome Sequencing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Illumina
  • 7.3: Agilent Technologies
  • 7.4: BGI
  • 7.5: PacBio
  • 7.6: Oxford Nanopore Technologies
  • 7.7: Azenta
  • 7.8: CD Genomics
  • 7.9: Novogene
  • 7.10: Eurofins Genomics